We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LYEL market cap is 531.06M. The company's latest EPS is USD -0.9234 and P/E is -2.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.25M | 49.6M | 1.35M | 596k | 317k |
| Operating Income | -66.44M | -14.78M | -62.56M | -65.91M | -59.04M |
| Net Income | -70.25M | -8.4M | -66.96M | -63.89M | -50.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 657k | 17.19M | 12.97M | 89.44M | 2.92M |
| Operating Income | -102.09M | -211.94M | -214.78M | -187.06M | -247.01M |
| Net Income | -129.38M | -204.47M | -250.22M | -183.12M | -234.63M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 977.27M | 937.56M | 880.45M | 835.35M | 794.99M |
| Total Liabilities | 157.24M | 104.31M | 96.62M | 98.5M | 97.42M |
| Total Equity | 820.03M | 833.25M | 783.83M | 736.86M | 697.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 555.63M | 908.28M | 1.13B | 937.56M | 750.03M |
| Total Liabilities | 147.58M | 189.84M | 197.62M | 104.31M | 95.08M |
| Total Equity | -111.11M | -292.53M | 929.79M | 833.25M | 654.95M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -129.29M | -169.56M | -46.21M | -85.37M | -123.06M |
| Investing | -58.19M | -11.54M | 32.15M | 185.07M | 284.74M |
| Financing | 9.77M | 10.64M | -69k | 1.13M | 984k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 39.47M | -160.87M | -126.25M | -169.56M | -163.69M |
| Investing | -422.43M | -273.52M | -121.57M | -11.54M | 184.05M |
| Financing | 351.16M | 476.79M | 401.24M | 10.64M | 1.74M |
| Market Cap | 531.06M |
| Price to Earnings Ratio | -2.35 |
| Price to Sales Ratio | 188.7 |
| Price to Cash Ratio | 3.79 |
| Price to Book Ratio | 0.84 |
| Dividend Yield | - |
| Shares Outstanding | 254.1M |
| Average Volume (1 week) | 662.83k |
| Average Volume (1 Month) | 961.33k |
| 52 Week Change | 3.98% |
| 52 Week High | 3.97 |
| 52 Week Low | 1.32 |
| Spread (Intraday) | 0.93 (31%) |
| Company Name | Lyell Immunopharma Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://lyell.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
